Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Bruker Corporation Raised FY23 Revenue Outlook To $2.88B-$2.91B Vs. $2.92B Estimate (Prior Outlook: $2.85B-$2.90B), Projects FY23 Adjusted EPS Of $2.48-$2.53 Vs. $2.55 Estimate

Author: Benzinga Newsdesk | February 13, 2024 08:17am

Organic revenue growth of 11.5%-12.5%, up 150 basis points (bps) at the midpoint from prior outlook of 9.5%-11.5%

Posted In: BRKR